Global Kinase Inhibitors Market Insights and Forecast to 2028

Global Kinase Inhibitors Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kinase Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Non-receptor Tyrosine Kinase Inhibitors
1.2.3 Receptor Tyrosine Kinase Inhibitors
1.2.4 Multikinase Inhibitors
1.2.5 Serine/Threonine Kinase Inhibitors
1.2.6 Protein Kinase C Inhibitors
1.2.7 RHO Kinase Inhibitors
1.2.8 Others
1.3 Market by Application
1.3.1 Global Kinase Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Inflammatory Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kinase Inhibitors Market Perspective (2017-2028)
2.2 Kinase Inhibitors Growth Trends by Region
2.2.1 Kinase Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Kinase Inhibitors Historic Market Size by Region (2017-2022)
2.2.3 Kinase Inhibitors Forecasted Market Size by Region (2023-2028)
2.3 Kinase Inhibitors Market Dynamics
2.3.1 Kinase Inhibitors Industry Trends
2.3.2 Kinase Inhibitors Market Drivers
2.3.3 Kinase Inhibitors Market Challenges
2.3.4 Kinase Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kinase Inhibitors Players by Revenue
3.1.1 Global Top Kinase Inhibitors Players by Revenue (2017-2022)
3.1.2 Global Kinase Inhibitors Revenue Market Share by Players (2017-2022)
3.2 Global Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kinase Inhibitors Revenue
3.4 Global Kinase Inhibitors Market Concentration Ratio
3.4.1 Global Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kinase Inhibitors Revenue in 2021
3.5 Kinase Inhibitors Key Players Head office and Area Served
3.6 Key Players Kinase Inhibitors Product Solution and Service
3.7 Date of Enter into Kinase Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kinase Inhibitors Breakdown Data by Type
4.1 Global Kinase Inhibitors Historic Market Size by Type (2017-2022)
4.2 Global Kinase Inhibitors Forecasted Market Size by Type (2023-2028)
5 Kinase Inhibitors Breakdown Data by Application
5.1 Global Kinase Inhibitors Historic Market Size by Application (2017-2022)
5.2 Global Kinase Inhibitors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Kinase Inhibitors Market Size (2017-2028)
6.2 North America Kinase Inhibitors Market Size by Type
6.2.1 North America Kinase Inhibitors Market Size by Type (2017-2022)
6.2.2 North America Kinase Inhibitors Market Size by Type (2023-2028)
6.2.3 North America Kinase Inhibitors Market Share by Type (2017-2028)
6.3 North America Kinase Inhibitors Market Size by Application
6.3.1 North America Kinase Inhibitors Market Size by Application (2017-2022)
6.3.2 North America Kinase Inhibitors Market Size by Application (2023-2028)
6.3.3 North America Kinase Inhibitors Market Share by Application (2017-2028)
6.4 North America Kinase Inhibitors Market Size by Country
6.4.1 North America Kinase Inhibitors Market Size by Country (2017-2022)
6.4.2 North America Kinase Inhibitors Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Kinase Inhibitors Market Size (2017-2028)
7.2 Europe Kinase Inhibitors Market Size by Type
7.2.1 Europe Kinase Inhibitors Market Size by Type (2017-2022)
7.2.2 Europe Kinase Inhibitors Market Size by Type (2023-2028)
7.2.3 Europe Kinase Inhibitors Market Share by Type (2017-2028)
7.3 Europe Kinase Inhibitors Market Size by Application
7.3.1 Europe Kinase Inhibitors Market Size by Application (2017-2022)
7.3.2 Europe Kinase Inhibitors Market Size by Application (2023-2028)
7.3.3 Europe Kinase Inhibitors Market Share by Application (2017-2028)
7.4 Europe Kinase Inhibitors Market Size by Country
7.4.1 Europe Kinase Inhibitors Market Size by Country (2017-2022)
7.4.2 Europe Kinase Inhibitors Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kinase Inhibitors Market Size (2017-2028)
8.2 Asia-Pacific Kinase Inhibitors Market Size by Type
8.2.1 Asia-Pacific Kinase Inhibitors Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Kinase Inhibitors Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Kinase Inhibitors Market Share by Type (2017-2028)
8.3 Asia-Pacific Kinase Inhibitors Market Size by Application
8.3.1 Asia-Pacific Kinase Inhibitors Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Kinase Inhibitors Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Kinase Inhibitors Market Share by Application (2017-2028)
8.4 Asia-Pacific Kinase Inhibitors Market Size by Region
8.4.1 Asia-Pacific Kinase Inhibitors Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Kinase Inhibitors Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Kinase Inhibitors Market Size (2017-2028)
9.2 Latin America Kinase Inhibitors Market Size by Type
9.2.1 Latin America Kinase Inhibitors Market Size by Type (2017-2022)
9.2.2 Latin America Kinase Inhibitors Market Size by Type (2023-2028)
9.2.3 Latin America Kinase Inhibitors Market Share by Type (2017-2028)
9.3 Latin America Kinase Inhibitors Market Size by Application
9.3.1 Latin America Kinase Inhibitors Market Size by Application (2017-2022)
9.3.2 Latin America Kinase Inhibitors Market Size by Application (2023-2028)
9.3.3 Latin America Kinase Inhibitors Market Share by Application (2017-2028)
9.4 Latin America Kinase Inhibitors Market Size by Country
9.4.1 Latin America Kinase Inhibitors Market Size by Country (2017-2022)
9.4.2 Latin America Kinase Inhibitors Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kinase Inhibitors Market Size (2017-2028)
10.2 Middle East & Africa Kinase Inhibitors Market Size by Type
10.2.1 Middle East & Africa Kinase Inhibitors Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Kinase Inhibitors Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Kinase Inhibitors Market Share by Type (2017-2028)
10.3 Middle East & Africa Kinase Inhibitors Market Size by Application
10.3.1 Middle East & Africa Kinase Inhibitors Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Kinase Inhibitors Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Kinase Inhibitors Market Share by Application (2017-2028)
10.4 Middle East & Africa Kinase Inhibitors Market Size by Country
10.4.1 Middle East & Africa Kinase Inhibitors Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Kinase Inhibitors Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kinase Inhibitors Introduction
11.1.4 Merck Revenue in Kinase Inhibitors Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Kinase Inhibitors Introduction
11.2.4 Novartis Revenue in Kinase Inhibitors Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Kinase Inhibitors Introduction
11.3.4 Pfizer Revenue in Kinase Inhibitors Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Kinase Inhibitors Introduction
11.4.4 Sanofi Revenue in Kinase Inhibitors Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Kinase Inhibitors Introduction
11.5.4 GlaxoSmithKline Revenue in Kinase Inhibitors Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Biogen Idec
11.6.1 Biogen Idec Company Details
11.6.2 Biogen Idec Business Overview
11.6.3 Biogen Idec Kinase Inhibitors Introduction
11.6.4 Biogen Idec Revenue in Kinase Inhibitors Business (2017-2022)
11.6.5 Biogen Idec Recent Developments
11.7 Bayer Healthcare Pharmaceuticals
11.7.1 Bayer Healthcare Pharmaceuticals Company Details
11.7.2 Bayer Healthcare Pharmaceuticals Business Overview
11.7.3 Bayer Healthcare Pharmaceuticals Kinase Inhibitors Introduction
11.7.4 Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022)
11.7.5 Bayer Healthcare Pharmaceuticals Recent Developments
11.8 Johnson
11.8.1 Johnson Company Details
11.8.2 Johnson Business Overview
11.8.3 Johnson Kinase Inhibitors Introduction
11.8.4 Johnson Revenue in Kinase Inhibitors Business (2017-2022)
11.8.5 Johnson Recent Developments
11.9 Tolero Pharmaceutical
11.9.1 Tolero Pharmaceutical Company Details
11.9.2 Tolero Pharmaceutical Business Overview
11.9.3 Tolero Pharmaceutical Kinase Inhibitors Introduction
11.9.4 Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2017-2022)
11.9.5 Tolero Pharmaceutical Recent Developments
11.10 Astellas Pharma Inc
11.10.1 Astellas Pharma Inc Company Details
11.10.2 Astellas Pharma Inc Business Overview
11.10.3 Astellas Pharma Inc Kinase Inhibitors Introduction
11.10.4 Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2017-2022)
11.10.5 Astellas Pharma Inc Recent Developments
11.11 Eli Lilly and Co
11.11.1 Eli Lilly and Co Company Details
11.11.2 Eli Lilly and Co Business Overview
11.11.3 Eli Lilly and Co Kinase Inhibitors Introduction
11.11.4 Eli Lilly and Co Revenue in Kinase Inhibitors Business (2017-2022)
11.11.5 Eli Lilly and Co Recent Developments
11.12 Incyte Corp
11.12.1 Incyte Corp Company Details
11.12.2 Incyte Corp Business Overview
11.12.3 Incyte Corp Kinase Inhibitors Introduction
11.12.4 Incyte Corp Revenue in Kinase Inhibitors Business (2017-2022)
11.12.5 Incyte Corp Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Kinase Inhibitors Introduction
11.13.4 AstraZeneca Revenue in Kinase Inhibitors Business (2017-2022)
11.13.5 AstraZeneca Recent Developments
11.14 Bristol-Myers Squibb
11.14.1 Bristol-Myers Squibb Company Details
11.14.2 Bristol-Myers Squibb Business Overview
11.14.3 Bristol-Myers Squibb Kinase Inhibitors Introduction
11.14.4 Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2017-2022)
11.14.5 Bristol-Myers Squibb Recent Developments
11.15 Boehringer Ingelheim International GmbH
11.15.1 Boehringer Ingelheim International GmbH Company Details
11.15.2 Boehringer Ingelheim International GmbH Business Overview
11.15.3 Boehringer Ingelheim International GmbH Kinase Inhibitors Introduction
11.15.4 Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2017-2022)
11.15.5 Boehringer Ingelheim International GmbH Recent Developments
11.16 F. Hoffmann-La Roche Ltd
11.16.1 F. Hoffmann-La Roche Ltd Company Details
11.16.2 F. Hoffmann-La Roche Ltd Business Overview
11.16.3 F. Hoffmann-La Roche Ltd Kinase Inhibitors Introduction
11.16.4 F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2017-2022)
11.16.5 F. Hoffmann-La Roche Ltd Recent Developments
11.17 Eisai Co., Ltd.
11.17.1 Eisai Co., Ltd. Company Details
11.17.2 Eisai Co., Ltd. Business Overview
11.17.3 Eisai Co., Ltd. Kinase Inhibitors Introduction
11.17.4 Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2017-2022)
11.17.5 Eisai Co., Ltd. Recent Developments
11.18 BerGenBio
11.18.1 BerGenBio Company Details
11.18.2 BerGenBio Business Overview
11.18.3 BerGenBio Kinase Inhibitors Introduction
11.18.4 BerGenBio Revenue in Kinase Inhibitors Business (2017-2022)
11.18.5 BerGenBio Recent Developments
11.19 Rigel Pharmaceuticals
11.19.1 Rigel Pharmaceuticals Company Details
11.19.2 Rigel Pharmaceuticals Business Overview
11.19.3 Rigel Pharmaceuticals Kinase Inhibitors Introduction
11.19.4 Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022)
11.19.5 Rigel Pharmaceuticals Recent Developments
11.20 Mirati Therapeutics
11.20.1 Mirati Therapeutics Company Details
11.20.2 Mirati Therapeutics Business Overview
11.20.3 Mirati Therapeutics Kinase Inhibitors Introduction
11.20.4 Mirati Therapeutics Revenue in Kinase Inhibitors Business (2017-2022)
11.20.5 Mirati Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Kinase Inhibitors Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Non-receptor Tyrosine Kinase Inhibitors
Table 3. Key Players of Receptor Tyrosine Kinase Inhibitors
Table 4. Key Players of Multikinase Inhibitors
Table 5. Key Players of Serine/Threonine Kinase Inhibitors
Table 6. Key Players of Protein Kinase C Inhibitors
Table 7. Key Players of RHO Kinase Inhibitors
Table 8. Key Players of Others
Table 9. Global Kinase Inhibitors Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Kinase Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Kinase Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Kinase Inhibitors Market Share by Region (2017-2022)
Table 13. Global Kinase Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Kinase Inhibitors Market Share by Region (2023-2028)
Table 15. Kinase Inhibitors Market Trends
Table 16. Kinase Inhibitors Market Drivers
Table 17. Kinase Inhibitors Market Challenges
Table 18. Kinase Inhibitors Market Restraints
Table 19. Global Kinase Inhibitors Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Kinase Inhibitors Revenue Share by Players (2017-2022)
Table 21. Global Top Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2021)
Table 22. Ranking of Global Top Kinase Inhibitors Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Kinase Inhibitors Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Kinase Inhibitors Product Solution and Service
Table 26. Date of Enter into Kinase Inhibitors Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Kinase Inhibitors Revenue Market Share by Type (2017-2022)
Table 30. Global Kinase Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Kinase Inhibitors Revenue Market Share by Type (2023-2028)
Table 32. Global Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Kinase Inhibitors Revenue Share by Application (2017-2022)
Table 34. Global Kinase Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Kinase Inhibitors Revenue Share by Application (2023-2028)
Table 36. North America Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Kinase Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Kinase Inhibitors Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Kinase Inhibitors Product
Table 69. Merck Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 70. Merck Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Kinase Inhibitors Product
Table 74. Novartis Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Kinase Inhibitors Product
Table 79. Pfizer Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Kinase Inhibitors Product
Table 84. Sanofi Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Kinase Inhibitors Product
Table 89. GlaxoSmithKline Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 90. GlaxoSmithKline Recent Developments
Table 91. Biogen Idec Company Details
Table 92. Biogen Idec Business Overview
Table 93. Biogen Idec Kinase Inhibitors Product
Table 94. Biogen Idec Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 95. Biogen Idec Recent Developments
Table 96. Bayer Healthcare Pharmaceuticals Company Details
Table 97. Bayer Healthcare Pharmaceuticals Business Overview
Table 98. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Product
Table 99. Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 100. Bayer Healthcare Pharmaceuticals Recent Developments
Table 101. Johnson Company Details
Table 102. Johnson Business Overview
Table 103. Johnson Kinase Inhibitors Product
Table 104. Johnson Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 105. Johnson Recent Developments
Table 106. Tolero Pharmaceutical Company Details
Table 107. Tolero Pharmaceutical Business Overview
Table 108. Tolero Pharmaceutical Kinase Inhibitors Product
Table 109. Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 110. Tolero Pharmaceutical Recent Developments
Table 111. Astellas Pharma Inc Company Details
Table 112. Astellas Pharma Inc Business Overview
Table 113. Astellas Pharma Inc Kinase Inhibitors Product
Table 114. Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 115. Astellas Pharma Inc Recent Developments
Table 116. Eli Lilly and Co Company Details
Table 117. Eli Lilly and Co Business Overview
Table 118. Eli Lilly and Co Kinase Inhibitors Product
Table 119. Eli Lilly and Co Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 120. Eli Lilly and Co Recent Developments
Table 121. Incyte Corp Company Details
Table 122. Incyte Corp Business Overview
Table 123. Incyte Corp Kinase Inhibitors Product
Table 124. Incyte Corp Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 125. Incyte Corp Recent Developments
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Kinase Inhibitors Product
Table 129. AstraZeneca Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 130. AstraZeneca Recent Developments
Table 131. Bristol-Myers Squibb Company Details
Table 132. Bristol-Myers Squibb Business Overview
Table 133. Bristol-Myers Squibb Kinase Inhibitors Product
Table 134. Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 135. Bristol-Myers Squibb Recent Developments
Table 136. Boehringer Ingelheim International GmbH Company Details
Table 137. Boehringer Ingelheim International GmbH Business Overview
Table 138. Boehringer Ingelheim International GmbH Kinase Inhibitors Product
Table 139. Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 140. Boehringer Ingelheim International GmbH Recent Developments
Table 141. F. Hoffmann-La Roche Ltd Company Details
Table 142. F. Hoffmann-La Roche Ltd Business Overview
Table 143. F. Hoffmann-La Roche Ltd Kinase Inhibitors Product
Table 144. F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 145. F. Hoffmann-La Roche Ltd Recent Developments
Table 146. Eisai Co., Ltd. Company Details
Table 147. Eisai Co., Ltd. Business Overview
Table 148. Eisai Co., Ltd. Kinase Inhibitors Product
Table 149. Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 150. Eisai Co., Ltd. Recent Developments
Table 151. BerGenBio Company Details
Table 152. BerGenBio Business Overview
Table 153. BerGenBio Kinase Inhibitors Product
Table 154. BerGenBio Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 155. BerGenBio Recent Developments
Table 156. Rigel Pharmaceuticals Company Details
Table 157. Rigel Pharmaceuticals Business Overview
Table 158. Rigel Pharmaceuticals Kinase Inhibitors Product
Table 159. Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 160. Rigel Pharmaceuticals Recent Developments
Table 161. Mirati Therapeutics Company Details
Table 162. Mirati Therapeutics Business Overview
Table 163. Mirati Therapeutics Kinase Inhibitors Product
Table 164. Mirati Therapeutics Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
Table 165. Mirati Therapeutics Recent Developments
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kinase Inhibitors Market Share by Type: 2021 VS 2028
Figure 2. Non-receptor Tyrosine Kinase Inhibitors Features
Figure 3. Receptor Tyrosine Kinase Inhibitors Features
Figure 4. Multikinase Inhibitors Features
Figure 5. Serine/Threonine Kinase Inhibitors Features
Figure 6. Protein Kinase C Inhibitors Features
Figure 7. RHO Kinase Inhibitors Features
Figure 8. Others Features
Figure 9. Global Kinase Inhibitors Market Share by Application: 2021 VS 2028
Figure 10. Oncology Case Studies
Figure 11. Inflammatory Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. Kinase Inhibitors Report Years Considered
Figure 14. Global Kinase Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Kinase Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Kinase Inhibitors Market Share by Region: 2021 VS 2028
Figure 17. Global Kinase Inhibitors Market Share by Players in 2021
Figure 18. Global Top Kinase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Kinase Inhibitors Revenue in 2021
Figure 20. North America Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Kinase Inhibitors Market Size Market Share by Type (2017-2028)
Figure 22. North America Kinase Inhibitors Market Size Market Share by Application (2017-2028)
Figure 23. North America Kinase Inhibitors Market Size Share by Country (2017-2028)
Figure 24. United States Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Kinase Inhibitors Market Size Market Share by Type (2017-2028)
Figure 28. Europe Kinase Inhibitors Market Size Market Share by Application (2017-2028)
Figure 29. Europe Kinase Inhibitors Market Size Share by Country (2017-2028)
Figure 30. Germany Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Kinase Inhibitors Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Kinase Inhibitors Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Kinase Inhibitors Market Size Share by Region (2017-2028)
Figure 40. China Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Kinase Inhibitors Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Kinase Inhibitors Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Kinase Inhibitors Market Size Share by Country (2017-2028)
Figure 50. Mexico Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Kinase Inhibitors Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Kinase Inhibitors Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Kinase Inhibitors Market Size Share by Country (2017-2028)
Figure 56. Turkey Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 64. Biogen Idec Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 65. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 66. Johnson Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 67. Tolero Pharmaceutical Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 68. Astellas Pharma Inc Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 69. Eli Lilly and Co Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 70. Incyte Corp Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure 71. AstraZeneca Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Erythrocyte Catalase Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Erythrocyte Catalase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ millio......

Global Endoenzyme Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Endoenzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The application scenarios of endozymes are very wide and can be used in many fields such as chemical reagents, medical treatment, and environmental protection. With The continuous development of science and technology, The application scenarios of endozymes will continue to expand. This will further promote......

Global CASP9 Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

CASP9 (Caspase 9) is a Protein Coding gene. Diseases associated with CASP9 include Cerebral Hypoxia and Colorectal Cancer. Among its related pathways are TNFR1 Pathway and Apoptosis and survival FAS signaling cascades. Gene Ontology (GO) annotations related to this gene include protein kinase binding and peptidase activity. An important paralog of this gene is CASP2. The global CASP9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing......

Global Collagenase Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 78

Collagenase, obtained from Clostridium histolyticum, is an enzyme used for tissue dissociation in vitro and thus for isolation of many different types of cells. These isolated cells are then used for numerous clinical and research applications. The global Collagenase market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 2.2% during The forecast period 2024-2030. The global collagenase market is mainly compos......

Global Industrial Enzymes Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 123

Enzymes are protein molecules functioning as specialized catalysts for chemical reactions. They have contributed greatly to The traditional and modern chemical industry by improving existing processes. Enzymes are natural catalysts. They are produced by living organisms to increase The rate of an immense and diverse set of chemical reactions required for life. They are involved in all processes essential for life such as DNA replication and transcription, protein synthesis, metabolism and signal......

Global Phytases Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Phytases market size was valued at US$ 490.1 million in 2023. With growing demand in downstream market, the Phytases is forecast to a readjusted size of US$ 732.7 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Phytases market. Phytases are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Trypsin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Trypsin market size was valued at US$ 214.3 million in 2023. With growing demand in downstream market, the Trypsin is forecast to a readjusted size of US$ 374.5 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Trypsin market. Trypsin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Cellulase Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Cellulase market size was valued at US$ 1980 million in 2023. With growing demand in downstream market, the Cellulase is forecast to a readjusted size of US$ 3084 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Cellulase market. Cellulase are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Restriction Endonucleases Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Restriction Endonucleases market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Restriction Endonucleases is forecast to a readjusted size of US$ 397 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Restriction Endonucleases market. Restriction Endonucleases are expected to show stable growth in the future m......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs